Home | Business News | Browse by Publication | P | Pharma Marketletter

Merz' Namenda performs well in USA.

Publication: Pharma Marketletter
Publication Date: 01-MAR-04
Format: Online - approximately 196 words
Delivery: Immediate Online Access
Full Article Title: Merz' Namenda performs well in USA.(Brief Article)

Article Excerpt
Frankfurt, Germany-headquartered Merz Pharma has reported the success of Namenda (memantine) following its US launch early this year (see also Marketletter January 19 and page 26 this issue) for the treatment of moderate-to-severe Alzheimer's disease.

At only a few weeks post US launch, already more Alzheimer's patients are receiving...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Pharma Marketletter
Hollis-Eden acquires Congressional.(Brief Article), March 01, 2004
Visiongain migraine and IBS market reports.(Brief Article), March 01, 2004
Cordis and Guidant to co-promote stents.(Brief Article), March 01, 2004
Workers protest over Merck KGaA's closure of French site.(Brief Articl..., March 01, 2004
UK NHS to offer free IVF treatment.(National Health Service, In Vitro ..., March 01, 2004

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.